A major breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in various forms of cancer, causing https://throbsocial.com/story24116811/nanobodies-revive-p53-a-promising-hope-for-tumor-therapy